Ding K, Liu H, Ma J, Yang H, et al. Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial. Haematologica 2023 Jan 26. doi: 10.3324/haematol.2022.282266.
PMID: 36700408